• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AC8
Click for more information
1.92% 13.3¢

AUSCANN GROUP HOLDINGS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

AusCann Group Holdings Ltd, formerly TW Holdings Limited, is an Australia-based company,... AusCann Group Holdings Ltd, formerly TW Holdings Limited, is an Australia-based company, which is engaged in the medical marijuana cultivation and distribution. The Company is in the process of researching and obtaining licenses for growing and distributions rights, as well as developing appropriate cultivation methods. The Company focuses on investigating other opportunities in the medical cannabis sector, including acquisition or investment in other international plant breeders, producers and suppliers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AC8 Change of Director's Interest Notice - P. MacLeman27/03/19
AC8 Change of Director's Interest Notice - M. Washer12/03/19
AC8 S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
AC8 Investor PresentationPRICE SENSITIVE07/03/19
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018PRICE SENSITIVE28/02/19
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEOPRICE SENSITIVE25/02/19
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharmPRICE SENSITIVE21/02/19
AC8 Appendix 3B - Release from Escrow07/02/19
AC8 Appointment of Joint Company Secretary01/02/19
AC8 December 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/01/19
AC8 AusCann Establishes Research and Development FacilityPRICE SENSITIVE25/01/19
AC8 AusCann JV commences first cultivation activity with KhironPRICE SENSITIVE22/01/19
AC8 Notification of Release of Securities from Escrow17/01/19
AC8 Final Director's Interest Notice02/01/19
AC8 AusCann Leadership Transition UpdatePRICE SENSITIVE17/12/18
AC8 Results of Annual General Meeting27/11/18
AC8 Annual General Meeting Presentation27/11/18
AC8 AC8 Moves First Products to Commercial Manufacturing SitePRICE SENSITIVE13/11/18
AC8 September 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE30/10/18
AC8 Annual Report26/10/18
AC8 Notice of Annual General Meeting/Proxy Form26/10/18
AC8 AusCann Releases Cannabinoid Medical Education Resources02/10/18
AC8 AusCann Joint Venture Signs MoU with Khiron Life SciencesPRICE SENSITIVE01/10/18
AC8 Pharmaceutical Executive Joins AusCann Board & Appendix 3X27/09/18
AC8 AusCann Announces Leadership TransitionPRICE SENSITIVE27/09/18
AC8 Appendix 4G and 2018 Corporate Governance Statement24/09/18
AC8 30 June 2018 Annual Financial Report24/09/18
AC8 AusCann Commences Trading on US OTCQX Market12/09/18
AC8 Progress Towards Production of Cannabinoid Medicines in FY1831/08/18
AC8 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/18
AC8 Successful Pilot Study of Final Dose Cannabinoid CapsulesPRICE SENSITIVE16/08/18
AC8 Change of Director's Interest Notice - B. McHarrie13/08/18
AC8 Appendix 3B09/08/18
AC8 AusCann Share Purchase Plan Raises $1.9mPRICE SENSITIVE09/08/18
AC8 June 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/07/18
AC8 Share Purchase Plan (SPP) Offer Document19/07/18 download Created with Sketch. 335.98KB
AC8 Response to ASX Aware QueryPRICE SENSITIVE19/07/18 download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase PlanPRICE SENSITIVE16/07/18 download Created with Sketch. 140.61KB
AC8 Appendix 3B & s708A(5)(e) Notice13/07/18 download Created with Sketch. 310.71KB
AC8 AusCann Completes A$33.4 million PlacementPRICE SENSITIVE05/07/18 download Created with Sketch. 144.31KB
AC8 Trading HaltPRICE SENSITIVE03/07/18 download Created with Sketch. 161.42KB
AC8 Australian Production Accelerates with Canadian EngagementsPRICE SENSITIVE25/06/18 download Created with Sketch. 129.73KB
AC8 Response to ASX Price and Volume QueryPRICE SENSITIVE20/06/18 download Created with Sketch. 472.66KB
AC8 AusCann Joint Venture Harvests Second Crop in ChilePRICE SENSITIVE07/06/18 download Created with Sketch. 711.89KB
AC8 Appendix 3B & s708A(5)(e) Notice15/05/18
AC8 Appendix 3B & s708A(5)(e) Notice04/05/18
AC8 Appendix 3B & s708A(5)(e) Notice02/05/18
AC8 March 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE26/04/18
AC8 AusCann and Canopy Growth Partnership ExpansionPRICE SENSITIVE24/04/18
AC8 Immediate access for Chilean patientsPRICE SENSITIVE28/03/18
AC8 Appendix 3B and s708A(5)(e) Notice19/03/18
AC8 AusCann Builds Momentum in H1 FY1828/02/18
AC8 Appendix 4D and 31 December 2017 Half Year ReportPRICE SENSITIVE28/02/18
AC8 s708A(5)(e) Notice12/02/18
AC8 Appendix 3B12/02/18
AC8 December 2017 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/01/18
AC8 HoA signed with Leading Wholesale Distributor in AustraliaPRICE SENSITIVE22/01/18
AC8 Appendix 3B - Release from Escrow19/01/18
AC8 World Class Cannabis Research in Australia17/01/18
AC8 Release of Securities from Escrow16/01/18
AC8 Appendix 3B09/01/18
AC8 Federal Government to Allow Cannabis ExportPRICE SENSITIVE04/01/18
AC8 AusCann Plants Second Crop in ChilePRICE SENSITIVE18/12/17
AC8 Final Director's Interest Notice15/12/17
AC8 Resignation of Executive Director15/12/17
AC8 Final Operational Licence Now in PlacePRICE SENSITIVE07/12/17
AC8 Trading HaltPRICE SENSITIVE06/12/17
AC8 Results of Annual General Meeting24/11/17
AC8 2017 AGM Presentation24/11/17
AC8 Chilean Cultivation Licence Secured for Second CropPRICE SENSITIVE22/11/17
AC8 Trading HaltPRICE SENSITIVE21/11/17
AC8 Change of Registered Office09/11/17
AC8 September 2017 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/17
AC8 Notice of Annual General Meeting/Proxy Form23/10/17
AC8 Medicinal Cannabis Legislation Amendment20/10/17
AC8 Appendix 4G and Corporate Governance Statement29/09/17
AC8 Annual Report29/09/17
AC8 Medical Liaison Managers Appointed14/09/17
AC8 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/17
AC8 Appendix 3B14/08/17
AC8 Australian Manufacturing Licence GrantedPRICE SENSITIVE09/08/17
AC8 Trading Halt Request07/08/17
AC8 Trading HaltPRICE SENSITIVE07/08/17
AC8 June 2017 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/07/17
AC8 Change of Auditor20/07/17
AC8 Auscann - Tasmanian Alkaloids Licences SecuredPRICE SENSITIVE11/07/17
AC8 Appointment of Chief Medical Advisor15/06/17
AC8 Initial Director's Interest Notice15/06/17
AC8 Appointment of Alternate Director15/06/17
AC8 Change to Managing Director Remuneration Package15/06/17
AC8 Improved Access For Critically Ill PatientsPRICE SENSITIVE14/06/17
AC8 Presentation - ASX CEO Spotlight Hong Kong and Singapore30/05/17
AC8 Ceasing to be a substantial holder25/05/17
AC8 Appendix 3B25/05/17
AC8 Cleansing ProspectusPRICE SENSITIVE23/05/17
AC8 AusCann Secures $12 Million in Institutional PlacementPRICE SENSITIVE19/05/17
AC8 Response to Media Commentary on Proposed Capital RaisingPRICE SENSITIVE18/05/17
AC8 Change of Director's Interest Notice x 318/05/17
AC8 Trading HaltPRICE SENSITIVE17/05/17
AC8 AusCann - Tasmanian Alkaloids Strategic PartnershipPRICE SENSITIVE17/05/17
AC8 Change of Director's Interest Notice - P. MacLeman
27/03/19
AC8 Change of Director's Interest Notice - M. Washer
12/03/19
AC8 S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
AC8 Investor Presentation
07/03/19PRICE SENSITIVE
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018
28/02/19PRICE SENSITIVE
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEO
25/02/19PRICE SENSITIVE
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharm
21/02/19PRICE SENSITIVE
AC8 Appendix 3B - Release from Escrow
07/02/19
AC8 Appointment of Joint Company Secretary
01/02/19
AC8 December 2018 Quarterly Activities and Cashflow Report
31/01/19PRICE SENSITIVE
AC8 AusCann Establishes Research and Development Facility
25/01/19PRICE SENSITIVE
AC8 AusCann JV commences first cultivation activity with Khiron
22/01/19PRICE SENSITIVE
AC8 Notification of Release of Securities from Escrow
17/01/19
AC8 Final Director's Interest Notice
02/01/19
AC8 AusCann Leadership Transition Update
17/12/18PRICE SENSITIVE
AC8 Results of Annual General Meeting
27/11/18
AC8 Annual General Meeting Presentation
27/11/18
AC8 AC8 Moves First Products to Commercial Manufacturing Site
13/11/18PRICE SENSITIVE
AC8 September 2018 Quarterly Activities and Cashflow Report
30/10/18PRICE SENSITIVE
AC8 Annual Report
26/10/18
AC8 Notice of Annual General Meeting/Proxy Form
26/10/18
AC8 AusCann Releases Cannabinoid Medical Education Resources
02/10/18
AC8 AusCann Joint Venture Signs MoU with Khiron Life Sciences
01/10/18PRICE SENSITIVE
AC8 Pharmaceutical Executive Joins AusCann Board & Appendix 3X
27/09/18
AC8 AusCann Announces Leadership Transition
27/09/18PRICE SENSITIVE
AC8 Appendix 4G and 2018 Corporate Governance Statement
24/09/18
AC8 30 June 2018 Annual Financial Report
24/09/18
AC8 AusCann Commences Trading on US OTCQX Market
12/09/18
AC8 Progress Towards Production of Cannabinoid Medicines in FY18
31/08/18
AC8 Appendix 4E and Preliminary Final Report
31/08/18PRICE SENSITIVE
AC8 Successful Pilot Study of Final Dose Cannabinoid Capsules
16/08/18PRICE SENSITIVE
AC8 Change of Director's Interest Notice - B. McHarrie
13/08/18
AC8 Appendix 3B
09/08/18
AC8 AusCann Share Purchase Plan Raises $1.9m
09/08/18PRICE SENSITIVE
AC8 June 2018 Quarterly Activities and Cashflow Report
31/07/18PRICE SENSITIVE
AC8 Share Purchase Plan (SPP) Offer Document
19/07/18 download Created with Sketch. 335.98KB
AC8 Response to ASX Aware Query
19/07/18PRICE SENSITIVE download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase Plan
16/07/18PRICE SENSITIVE download Created with Sketch. 140.61KB
AC8 Appendix 3B & s708A(5)(e) Notice
13/07/18 download Created with Sketch. 310.71KB
AC8 AusCann Completes A$33.4 million Placement
05/07/18PRICE SENSITIVE download Created with Sketch. 144.31KB
AC8 Trading Halt
03/07/18PRICE SENSITIVE download Created with Sketch. 161.42KB
AC8 Australian Production Accelerates with Canadian Engagements
25/06/18PRICE SENSITIVE download Created with Sketch. 129.73KB
AC8 Response to ASX Price and Volume Query
20/06/18PRICE SENSITIVE download Created with Sketch. 472.66KB
AC8 AusCann Joint Venture Harvests Second Crop in Chile
07/06/18PRICE SENSITIVE download Created with Sketch. 711.89KB
AC8 Appendix 3B & s708A(5)(e) Notice
15/05/18
AC8 Appendix 3B & s708A(5)(e) Notice
04/05/18
AC8 Appendix 3B & s708A(5)(e) Notice
02/05/18
AC8 March 2018 Quarterly Activities and Cashflow Report
26/04/18PRICE SENSITIVE
AC8 AusCann and Canopy Growth Partnership Expansion
24/04/18PRICE SENSITIVE
AC8 Immediate access for Chilean patients
28/03/18PRICE SENSITIVE
AC8 Appendix 3B and s708A(5)(e) Notice
19/03/18
AC8 AusCann Builds Momentum in H1 FY18
28/02/18
AC8 Appendix 4D and 31 December 2017 Half Year Report
28/02/18PRICE SENSITIVE
AC8 s708A(5)(e) Notice
12/02/18
AC8 Appendix 3B
12/02/18
AC8 December 2017 Quarterly Activities and Cashflow Reports
31/01/18PRICE SENSITIVE
AC8 HoA signed with Leading Wholesale Distributor in Australia
22/01/18PRICE SENSITIVE
AC8 Appendix 3B - Release from Escrow
19/01/18
AC8 World Class Cannabis Research in Australia
17/01/18
AC8 Release of Securities from Escrow
16/01/18
AC8 Appendix 3B
09/01/18
AC8 Federal Government to Allow Cannabis Export
04/01/18PRICE SENSITIVE
AC8 AusCann Plants Second Crop in Chile
18/12/17PRICE SENSITIVE
AC8 Final Director's Interest Notice
15/12/17
AC8 Resignation of Executive Director
15/12/17
AC8 Final Operational Licence Now in Place
07/12/17PRICE SENSITIVE
AC8 Trading Halt
06/12/17PRICE SENSITIVE
AC8 Results of Annual General Meeting
24/11/17
AC8 2017 AGM Presentation
24/11/17
AC8 Chilean Cultivation Licence Secured for Second Crop
22/11/17PRICE SENSITIVE
AC8 Trading Halt
21/11/17PRICE SENSITIVE
AC8 Change of Registered Office
09/11/17
AC8 September 2017 Quarterly Activities and Cashflow Report
31/10/17PRICE SENSITIVE
AC8 Notice of Annual General Meeting/Proxy Form
23/10/17
AC8 Medicinal Cannabis Legislation Amendment
20/10/17
AC8 Appendix 4G and Corporate Governance Statement
29/09/17
AC8 Annual Report
29/09/17
AC8 Medical Liaison Managers Appointed
14/09/17
AC8 Appendix 4E and Preliminary Final Report
31/08/17PRICE SENSITIVE
AC8 Appendix 3B
14/08/17
AC8 Australian Manufacturing Licence Granted
09/08/17PRICE SENSITIVE
AC8 Trading Halt Request
07/08/17
AC8 Trading Halt
07/08/17PRICE SENSITIVE
AC8 June 2017 Quarterly Activities and Cashflow Report
31/07/17PRICE SENSITIVE
AC8 Change of Auditor
20/07/17
AC8 Auscann - Tasmanian Alkaloids Licences Secured
11/07/17PRICE SENSITIVE
AC8 Appointment of Chief Medical Advisor
15/06/17
AC8 Initial Director's Interest Notice
15/06/17
AC8 Appointment of Alternate Director
15/06/17
AC8 Change to Managing Director Remuneration Package
15/06/17
AC8 Improved Access For Critically Ill Patients
14/06/17PRICE SENSITIVE
AC8 Presentation - ASX CEO Spotlight Hong Kong and Singapore
30/05/17
AC8 Ceasing to be a substantial holder
25/05/17
AC8 Appendix 3B
25/05/17
AC8 Cleansing Prospectus
23/05/17PRICE SENSITIVE
AC8 AusCann Secures $12 Million in Institutional Placement
19/05/17PRICE SENSITIVE
AC8 Response to Media Commentary on Proposed Capital Raising
18/05/17PRICE SENSITIVE
AC8 Change of Director's Interest Notice x 3
18/05/17
AC8 Trading Halt
17/05/17PRICE SENSITIVE
AC8 AusCann - Tasmanian Alkaloids Strategic Partnership
17/05/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.